Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 1.643M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 0.00% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
Profile
| Stemcell Holdings Inc, through its subsidiary, is engaged in the regenerative medicine-related business which includes but is not limited to providing technical assistance to the culturing, storing and delivery of stem cells and administrative and consulting services to clinics. The company provides two different options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells and natural killer cells. |
| URL | https://www.stemcell-holdings.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | |
| Industry | |
| Equity Style | N/A |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Stemcell Holdings Inc, through its subsidiary, is engaged in the regenerative medicine-related business which includes but is not limited to providing technical assistance to the culturing, storing and delivery of stem cells and administrative and consulting services to clinics. The company provides two different options for stem cell regenerative therapy: autologous adipose derived mesenchymal stem cells and natural killer cells. |
| URL | https://www.stemcell-holdings.com |
| Investor Relations URL | N/A |
| HQ State/Province | N/A |
| Sector | |
| Industry | |
| Equity Style | N/A |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |